{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:13:22Z","timestamp":1791346402613,"version":"4.3.1"},"reference-count":228,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lyme borreliosis is the most common vectorborne disease in the northern hemisphere. It usually begins with erythema migrans; early disseminated infection particularly causes multiple erythema migrans or neurologic disease, and late manifestations predominantly include arthritis in North America, and acrodermatitis chronica atrophicans (ACA) in Europe. Diagnosis of Lyme borreliosis is based on characteristic clinical signs and symptoms, complemented by serological confirmation of infection once an antibody response has been mounted. Manifestations usually respond to appropriate antibiotic regimens, but the disease can be followed by sequelae, such as immune arthritis or residual damage to affected tissues. A subset of individuals reports persistent symptoms, including fatigue, pain, arthralgia, and neurocognitive symptoms, which in some people are severe enough to fulfil the criteria for post-treatment Lyme disease syndrome. The reported prevalence of such persistent symptoms following antimicrobial treatment varies considerably, and its pathophysiology is unclear. Persistent active infection in humans has not been identified as a cause of this syndrome, and randomized treatment trials have invariably failed to show any benefit of prolonged antibiotic treatment. For prevention of Lyme borreliosis, post-exposure prophylaxis may be indicated in specific cases, and novel vaccine strategies are under development.<\/jats:p>","DOI":"10.1136\/bmj.m1041","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T14:25:11Z","timestamp":1590503111000},"page":"m1041","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":131,"title":["Lyme borreliosis: diagnosis and management"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct03769194","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bart Jan","family":"Kullberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig D","family":"Vrijmoeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek","family":"van de Schoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"2020062510350261000_369.may26_2.m1041.1","doi-asserted-by":"publisher","DOI":"10.1038\/37551"},{"key":"2020062510350261000_369.may26_2.m1041.2","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2020062510350261000_369.may26_2.m1041.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00464-8"},{"key":"2020062510350261000_369.may26_2.m1041.4","doi-asserted-by":"publisher","DOI":"10.1186\/s12942-018-0163-7"},{"key":"2020062510350261000_369.may26_2.m1041.5","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00609-17"},{"key":"2020062510350261000_369.may26_2.m1041.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10482-014-0164-x"},{"key":"2020062510350261000_369.may26_2.m1041.7","doi-asserted-by":"crossref","unstructured":"Margos G Gofton A Wibberg D . The genus Borrelia reloaded. PLoS One 2018;13:e0208432.","DOI":"10.1371\/journal.pone.0208432"},{"key":"2020062510350261000_369.may26_2.m1041.8","doi-asserted-by":"crossref","unstructured":"Gupta RS . Distinction between Borrelia and Borreliella is more robustly supported by molecular and phenotypic characteristics than all other neighbouring prokaryotic genera: Response to Margos\u2019 et al. \u201cThe genus Borrelia reloaded. PLoS One 2019;14:e0221397.","DOI":"10.1371\/journal.pone.0221397"},{"key":"2020062510350261000_369.may26_2.m1041.9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/vbz.2018.2323","article-title":"Human-biting Ixodes ticks and pathogen prevalence from California, Oregon, and Washington","volume":"19","author":"Xu","year":"2019","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2020062510350261000_369.may26_2.m1041.10","doi-asserted-by":"crossref","unstructured":"Hofhuis A van de Kassteele J Sprong H . Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model. PLoS One 2017;12:e0181807.","DOI":"10.1371\/journal.pone.0181807"},{"key":"2020062510350261000_369.may26_2.m1041.11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ttbdis.2015.08.009","article-title":"A prospective study on the incidence of Borrelia burgdorferi sensu lato infection after a tick bite in Sweden and on the Aland Islands, Finland (2008-2009)","volume":"7","author":"Wilhelmsson","year":"2016","journal-title":"Ticks Tick Borne Dis"},{"key":"2020062510350261000_369.may26_2.m1041.12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ttbdis.2011.05.002","article-title":"Prospective study on the incidence of infection by Borrelia burgdorferi sensu lato after a tick bite in a highly endemic area of Switzerland","volume":"2","author":"Huegli","year":"2011","journal-title":"Ticks Tick Borne Dis"},{"key":"2020062510350261000_369.may26_2.m1041.13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq097"},{"key":"2020062510350261000_369.may26_2.m1041.14","unstructured":"Lindgren E Jaenson TGT . Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. WHO Regional Office for Europe, 2006, http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0006\/96819\/E89522.pdf."},{"key":"2020062510350261000_369.may26_2.m1041.15","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdw017"},{"key":"2020062510350261000_369.may26_2.m1041.16","doi-asserted-by":"crossref","first-page":"19906","DOI":"10.2807\/ese.16.27.19906-en","article-title":"Lyme borreliosis in Europe","volume":"16","author":"Rizzoli","year":"2011","journal-title":"Euro Surveill"},{"key":"2020062510350261000_369.may26_2.m1041.17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.Es.2017.22.27.30569"},{"key":"2020062510350261000_369.may26_2.m1041.18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6717e1"},{"key":"2020062510350261000_369.may26_2.m1041.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278331"},{"key":"2020062510350261000_369.may26_2.m1041.20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13071-018-2744-5","article-title":"Control of Lyme borreliosis and other Ixodes ricinus-borne diseases","volume":"11","author":"Sprong","year":"2018","journal-title":"Parasit Vectors"},{"key":"2020062510350261000_369.may26_2.m1041.21","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.00108119"},{"key":"2020062510350261000_369.may26_2.m1041.22","doi-asserted-by":"crossref","unstructured":"Mac S da Silva SR Sander B . The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review. PLoS One 2019;14:e0210280.","DOI":"10.1371\/journal.pone.0210280"},{"key":"2020062510350261000_369.may26_2.m1041.23","unstructured":"European Parliament. Parliament calls for \u201calarming\u201d spread of Lyme disease to be tackled 2018. https:\/\/www.europarl.europa.eu\/news\/en\/press-room\/20181106IPR18328\/parliament-calls-for-alarming-spread-of-lyme-disease-to-be-tackled"},{"key":"2020062510350261000_369.may26_2.m1041.24","unstructured":"NIH. Strategic plan for tickborne disease research, 2019. https:\/\/www.niaid.nih.gov\/sites\/default\/files\/NIH-Strategic-Plan-Tickborne-Disease-Research-2019.pdf"},{"key":"2020062510350261000_369.may26_2.m1041.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03175.x"},{"key":"2020062510350261000_369.may26_2.m1041.26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","article-title":"To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis","volume":"24","author":"Dessau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2020062510350261000_369.may26_2.m1041.27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00296-007-0333-6","article-title":"Seronegative Lyme arthritis","volume":"27","author":"Holl-Wieden","year":"2007","journal-title":"Rheumatol Int"},{"key":"2020062510350261000_369.may26_2.m1041.28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.32.6.1519-1525.1994","article-title":"Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis","volume":"32","author":"Hammers-Berggen","year":"1994","journal-title":"J Clin Microbiol"},{"key":"2020062510350261000_369.may26_2.m1041.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00046-7"},{"key":"2020062510350261000_369.may26_2.m1041.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-006-0694-y"},{"key":"2020062510350261000_369.may26_2.m1041.31","doi-asserted-by":"publisher","DOI":"10.1086\/322669"},{"key":"2020062510350261000_369.may26_2.m1041.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2008.08.016"},{"key":"2020062510350261000_369.may26_2.m1041.33","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.8.910-917.2005"},{"key":"2020062510350261000_369.may26_2.m1041.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.30384"},{"key":"2020062510350261000_369.may26_2.m1041.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1294-1301.2005"},{"key":"2020062510350261000_369.may26_2.m1041.36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw299"},{"key":"2020062510350261000_369.may26_2.m1041.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.2.399"},{"key":"2020062510350261000_369.may26_2.m1041.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01799.x"},{"key":"2020062510350261000_369.may26_2.m1041.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.04.007"},{"key":"2020062510350261000_369.may26_2.m1041.40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694"},{"key":"2020062510350261000_369.may26_2.m1041.41","doi-asserted-by":"crossref","first-page":"O786","DOI":"10.1111\/1469-0691.12583","article-title":"The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful","volume":"20","author":"Dessau","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020062510350261000_369.may26_2.m1041.42","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw112"},{"key":"2020062510350261000_369.may26_2.m1041.43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12879-019-4323-6","article-title":"Validation of cellular tests for Lyme borreliosis (VICTORY) study","volume":"19","author":"van de Schoor","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0701-z"},{"key":"2020062510350261000_369.may26_2.m1041.45","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00167-09"},{"key":"2020062510350261000_369.may26_2.m1041.46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/23744235.2016.1144931","article-title":"Validate or falsify: lessons learned from a microscopy method claimed to be useful for detecting Borrelia and Babesia organisms in human blood","volume":"48","author":"Aase","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"2020062510350261000_369.may26_2.m1041.47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10408363.2018.1450353","article-title":"Laboratory diagnosis of Lyme borreliosis: current state of the art and future perspectives","volume":"55","author":"Lohr","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2020062510350261000_369.may26_2.m1041.48","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1468-4"},{"key":"2020062510350261000_369.may26_2.m1041.49","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2016.1246959"},{"key":"2020062510350261000_369.may26_2.m1041.50","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00109-08"},{"key":"2020062510350261000_369.may26_2.m1041.51","doi-asserted-by":"crossref","unstructured":"Stupica D Lusa L Maraspin V . Correlation of culture positivity, PCR positivity, and burden of Borrelia burgdorferi sensu lato in skin samples of erythema migrans patients with clinical findings. PLoS One 2015;10:e0136600.","DOI":"10.1371\/journal.pone.0136600"},{"key":"2020062510350261000_369.may26_2.m1041.52","doi-asserted-by":"publisher","DOI":"10.2165\/0128071-200809060-00002"},{"key":"2020062510350261000_369.may26_2.m1041.53","doi-asserted-by":"publisher","DOI":"10.1086\/323424"},{"key":"2020062510350261000_369.may26_2.m1041.54","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw417"},{"key":"2020062510350261000_369.may26_2.m1041.55","first-page":"515","article-title":"Solitary borrelial lymphocytoma in adult patients","volume":"114","author":"Maraspin","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"2020062510350261000_369.may26_2.m1041.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2003.00167.x"},{"key":"2020062510350261000_369.may26_2.m1041.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1988.tb31833.x"},{"key":"2020062510350261000_369.may26_2.m1041.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.02.004"},{"key":"2020062510350261000_369.may26_2.m1041.59","doi-asserted-by":"crossref","unstructured":"Waddell LA Greig J Mascarenhas M . The accuracy of diagnostic tests for Lyme disease in humans, a systematic review and meta-analysis of North American research. PLoS One 2016;11:e0168613.","DOI":"10.1371\/journal.pone.0168613"},{"key":"2020062510350261000_369.may26_2.m1041.60","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390505"},{"key":"2020062510350261000_369.may26_2.m1041.61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1964-x"},{"key":"2020062510350261000_369.may26_2.m1041.62","doi-asserted-by":"publisher","DOI":"10.2165\/00066982-200005020-00007"},{"key":"2020062510350261000_369.may26_2.m1041.63","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000172903.14077.4c"},{"key":"2020062510350261000_369.may26_2.m1041.64","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00410-08"},{"key":"2020062510350261000_369.may26_2.m1041.65","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.9.1663"},{"key":"2020062510350261000_369.may26_2.m1041.66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"2020062510350261000_369.may26_2.m1041.67","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.10.1571"},{"key":"2020062510350261000_369.may26_2.m1041.68","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269672.17807.e0"},{"key":"2020062510350261000_369.may26_2.m1041.69","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00341-09"},{"key":"2020062510350261000_369.may26_2.m1041.70","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300212"},{"key":"2020062510350261000_369.may26_2.m1041.71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J Neuroinflammation"},{"key":"2020062510350261000_369.may26_2.m1041.72","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00084-11"},{"key":"2020062510350261000_369.may26_2.m1041.73","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00353-13"},{"key":"2020062510350261000_369.may26_2.m1041.74","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1157-6"},{"key":"2020062510350261000_369.may26_2.m1041.75","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.484-509.2005"},{"key":"2020062510350261000_369.may26_2.m1041.76","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.10.5080-5084.2005"},{"key":"2020062510350261000_369.may26_2.m1041.77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332004"},{"key":"2020062510350261000_369.may26_2.m1041.78","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.1.61"},{"key":"2020062510350261000_369.may26_2.m1041.79","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-006-0659-1"},{"key":"2020062510350261000_369.may26_2.m1041.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(95)99915-9"},{"key":"2020062510350261000_369.may26_2.m1041.81","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-5-725"},{"key":"2020062510350261000_369.may26_2.m1041.82","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000884"},{"key":"2020062510350261000_369.may26_2.m1041.83","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-006-0167-2"},{"key":"2020062510350261000_369.may26_2.m1041.84","first-page":"253","article-title":"Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients","volume":"263","author":"Asbrink","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"2020062510350261000_369.may26_2.m1041.85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ttbdis.2016.11.011","article-title":"Pathogenetic implications of the age at time of diagnosis and skin location for acrodermatitis chronica atrophicans","volume":"8","author":"Ogrinc","year":"2017","journal-title":"Ticks Tick Borne Dis"},{"key":"2020062510350261000_369.may26_2.m1041.86","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaad.2015.10.046","article-title":"Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and\/or polymerase chain reaction (PCR)-documented cases","volume":"74","author":"Lenormand","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2020062510350261000_369.may26_2.m1041.87","first-page":"176","article-title":"Erythematous pigmentation of the arm for more than ten years","volume":"66","author":"Agterof","year":"2008","journal-title":"Neth J Med"},{"key":"2020062510350261000_369.may26_2.m1041.88","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11940-013-0240-y","article-title":"Nervous system Lyme disease: diagnosis and treatment","volume":"15","author":"Halperin","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"2020062510350261000_369.may26_2.m1041.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2018.11.019"},{"key":"2020062510350261000_369.may26_2.m1041.90","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/INF.0000000000001653","article-title":"Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics","volume":"36","author":"Sodermark","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2020062510350261000_369.may26_2.m1041.91","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10337"},{"key":"2020062510350261000_369.may26_2.m1041.92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2016.11.003","article-title":"A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease","volume":"87","author":"Wormser","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.93","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232102"},{"key":"2020062510350261000_369.may26_2.m1041.94","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00146"},{"key":"2020062510350261000_369.may26_2.m1041.95","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0340-2"},{"key":"2020062510350261000_369.may26_2.m1041.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.09.007"},{"key":"2020062510350261000_369.may26_2.m1041.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.01.044"},{"key":"2020062510350261000_369.may26_2.m1041.98","first-page":"202","article-title":"Lyme carditis\u2014diagnosis, treatment and prognosis","volume":"112","author":"Scheffold","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"2020062510350261000_369.may26_2.m1041.99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001253220407"},{"key":"2020062510350261000_369.may26_2.m1041.100","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs027"},{"key":"2020062510350261000_369.may26_2.m1041.101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60103-7"},{"key":"2020062510350261000_369.may26_2.m1041.102","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.4.708"},{"key":"2020062510350261000_369.may26_2.m1041.103","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2010.0230"},{"key":"2020062510350261000_369.may26_2.m1041.104","unstructured":"Centers for Disease Control and Prevention. Lyme disease: data and Surveillance. 2019. https:\/\/www.cdc.gov\/lyme\/datasurveillance\/index.html."},{"key":"2020062510350261000_369.may26_2.m1041.105","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux047"},{"key":"2020062510350261000_369.may26_2.m1041.106","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/jac\/dkx534","article-title":"Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial","volume":"73","author":"Stupica","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020062510350261000_369.may26_2.m1041.107","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0031-3955(16)33713-0","article-title":"Spirochetal infections","volume":"26","author":"Taber","year":"1979","journal-title":"Pediatr Clin North Am"},{"key":"2020062510350261000_369.may26_2.m1041.108","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-1-67"},{"key":"2020062510350261000_369.may26_2.m1041.109","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03370240064038"},{"key":"2020062510350261000_369.may26_2.m1041.110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006454-198804000-00010","article-title":"Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy","volume":"7","author":"Weber","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"2020062510350261000_369.may26_2.m1041.111","first-page":"256","article-title":"Listeriosis and borreliosis as causes of antepartum fever","volume":"62","author":"Shirts","year":"1983","journal-title":"Obstet Gynecol"},{"key":"2020062510350261000_369.may26_2.m1041.112","doi-asserted-by":"crossref","unstructured":"Waddell LA Greig J Lindsay LR Hinckley AF Ogden NH . A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS One 2018;13:e0207067.","DOI":"10.1371\/journal.pone.0207067"},{"key":"2020062510350261000_369.may26_2.m1041.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.07.019"},{"key":"2020062510350261000_369.may26_2.m1041.114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1904170116"},{"key":"2020062510350261000_369.may26_2.m1041.115","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jamadermatol.2018.3186","article-title":"Efficacy and safety of antibiotic therapy in early cutaneous Lyme borreliosis: a network meta-analysis","volume":"154","author":"Torbahn","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2020062510350261000_369.may26_2.m1041.116","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/INF.0000000000000804","article-title":"Azithromycin is equally effective as amoxicillin in children with solitary erythema migrans","volume":"34","author":"Arnez","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2020062510350261000_369.may26_2.m1041.117","doi-asserted-by":"publisher","DOI":"10.1007\/BF01710737"},{"key":"2020062510350261000_369.may26_2.m1041.118","doi-asserted-by":"publisher","DOI":"10.1007\/BF01780661"},{"key":"2020062510350261000_369.may26_2.m1041.119","doi-asserted-by":"publisher","DOI":"10.1007\/s150100050069"},{"key":"2020062510350261000_369.may26_2.m1041.120","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-9-199605010-00002"},{"key":"2020062510350261000_369.may26_2.m1041.121","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-9-200305060-00005"},{"key":"2020062510350261000_369.may26_2.m1041.122","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis402"},{"key":"2020062510350261000_369.may26_2.m1041.123","doi-asserted-by":"publisher","DOI":"10.1086\/649920"},{"key":"2020062510350261000_369.may26_2.m1041.124","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/ene.12744","article-title":"Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis\u2014a systematic review","volume":"22","author":"Dersch","year":"2015","journal-title":"Eur J Neurol"},{"key":"2020062510350261000_369.may26_2.m1041.125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2010.01482.x"},{"key":"2020062510350261000_369.may26_2.m1041.126","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70119-4"},{"key":"2020062510350261000_369.may26_2.m1041.127","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12420","article-title":"Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension","volume":"21","author":"Bremell","year":"2014","journal-title":"Eur J Neurol"},{"key":"2020062510350261000_369.may26_2.m1041.128","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370616"},{"key":"2020062510350261000_369.may26_2.m1041.129","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00040031677015"},{"key":"2020062510350261000_369.may26_2.m1041.130","doi-asserted-by":"publisher","DOI":"10.1002\/art.22131"},{"key":"2020062510350261000_369.may26_2.m1041.131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01780666","article-title":"Success and failure in the treatment of acrodermatitis chronica atrophicans","volume":"24","author":"Aberer","year":"1996","journal-title":"Infection"},{"key":"2020062510350261000_369.may26_2.m1041.132","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2002.01336.x"},{"key":"2020062510350261000_369.may26_2.m1041.133","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyi129"},{"key":"2020062510350261000_369.may26_2.m1041.134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12879-019-3949-8","article-title":"Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)","volume":"19","author":"Vrijmoeth","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.135","doi-asserted-by":"crossref","unstructured":"Embers ME Barthold SW Borda JT . Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 2012;7:e29914.","DOI":"10.1371\/journal.pone.0029914"},{"key":"2020062510350261000_369.may26_2.m1041.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.06.007"},{"key":"2020062510350261000_369.may26_2.m1041.137","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90208-7"},{"key":"2020062510350261000_369.may26_2.m1041.138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114362"},{"key":"2020062510350261000_369.may26_2.m1041.139","doi-asserted-by":"crossref","unstructured":"Lochhead RB Arvikar SL Aversa JM . Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis. Cell Microbiol 2018 e12954.","DOI":"10.1111\/cmi.12954"},{"key":"2020062510350261000_369.may26_2.m1041.140","first-page":"930","article-title":"T-Helper 17 cell cytokine responses in Lyme disease correlate with Borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.141","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.02.005","article-title":"Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis","volume":"69","author":"Crowley","year":"2016","journal-title":"J Autoimmun"},{"key":"2020062510350261000_369.may26_2.m1041.142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007263230402"},{"key":"2020062510350261000_369.may26_2.m1041.143","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/art.40039","article-title":"MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with postinfectious Lyme arthritis","volume":"69","author":"Lochhead","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020062510350261000_369.may26_2.m1041.144","doi-asserted-by":"publisher","DOI":"10.1002\/art.34383"},{"key":"2020062510350261000_369.may26_2.m1041.145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02756.x"},{"key":"2020062510350261000_369.may26_2.m1041.146","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2012.01690.x"},{"key":"2020062510350261000_369.may26_2.m1041.147","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080421"},{"key":"2020062510350261000_369.may26_2.m1041.148","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix568"},{"key":"2020062510350261000_369.may26_2.m1041.149","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70852-7"},{"key":"2020062510350261000_369.may26_2.m1041.150","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.05.011"},{"key":"2020062510350261000_369.may26_2.m1041.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.01.008"},{"key":"2020062510350261000_369.may26_2.m1041.152","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ735"},{"key":"2020062510350261000_369.may26_2.m1041.153","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1186\/s12879-019-4452-y","article-title":"Cognitive impairments in patients with persistent symptoms attributed to Lyme disease","volume":"19","author":"Berende","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.154","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1212\/WNL.0000000000007186","article-title":"Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis","volume":"92","author":"Berende","year":"2019","journal-title":"Neurology"},{"key":"2020062510350261000_369.may26_2.m1041.155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment Lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2020062510350261000_369.may26_2.m1041.156","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63975"},{"key":"2020062510350261000_369.may26_2.m1041.157","doi-asserted-by":"publisher","DOI":"10.1086\/508667"},{"key":"2020062510350261000_369.may26_2.m1041.158","unstructured":"Centers for Disease Control and Prevention. Lyme disease (Borrelia burgdorferi) 2017 case definition. 2017"},{"key":"2020062510350261000_369.may26_2.m1041.159","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.05.036"},{"key":"2020062510350261000_369.may26_2.m1041.160","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit810"},{"key":"2020062510350261000_369.may26_2.m1041.161","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00071-16"},{"key":"2020062510350261000_369.may26_2.m1041.162","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit735"},{"key":"2020062510350261000_369.may26_2.m1041.163","doi-asserted-by":"crossref","unstructured":"Sjowall J Fryland L Nordberg M . Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS One 2011;6:e18220.","DOI":"10.1371\/journal.pone.0018220"},{"key":"2020062510350261000_369.may26_2.m1041.164","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.03.002"},{"key":"2020062510350261000_369.may26_2.m1041.165","doi-asserted-by":"publisher","DOI":"10.1086\/432733"},{"key":"2020062510350261000_369.may26_2.m1041.166","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/jcm7120506","article-title":"Clinical course, serologic response, and long-term outcome in elderly patients with early Lyme Borreliosis","volume":"7","author":"Borsic","year":"2018","journal-title":"J Clin Med"},{"key":"2020062510350261000_369.may26_2.m1041.167","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/jwh.2008.1193","article-title":"Implications of gender in chronic Lyme disease","volume":"18","author":"Wormser","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"2020062510350261000_369.may26_2.m1041.168","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw189"},{"key":"2020062510350261000_369.may26_2.m1041.169","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-8-199410150-00002"},{"key":"2020062510350261000_369.may26_2.m1041.170","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.02.022"},{"key":"2020062510350261000_369.may26_2.m1041.171","doi-asserted-by":"publisher","DOI":"10.1086\/516171"},{"key":"2020062510350261000_369.may26_2.m1041.172","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med Sci Monit"},{"key":"2020062510350261000_369.may26_2.m1041.173","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450202"},{"key":"2020062510350261000_369.may26_2.m1041.174","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000071227.23769.9E"},{"key":"2020062510350261000_369.may26_2.m1041.175","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000284604.61160.2d"},{"key":"2020062510350261000_369.may26_2.m1041.176","first-page":"489","article-title":"Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial","volume":"99","author":"Cameron","year":"2008","journal-title":"Minerva Med"},{"key":"2020062510350261000_369.may26_2.m1041.177","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505425"},{"key":"2020062510350261000_369.may26_2.m1041.178","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2017.12.006"},{"key":"2020062510350261000_369.may26_2.m1041.179","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X01206010079"},{"key":"2020062510350261000_369.may26_2.m1041.180","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2012.08.009"},{"key":"2020062510350261000_369.may26_2.m1041.181","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.014"},{"key":"2020062510350261000_369.may26_2.m1041.182","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000068030.26992.25"},{"key":"2020062510350261000_369.may26_2.m1041.183","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12879-014-0543-y","article-title":"Persistent Lyme empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis","volume":"14","author":"Berende","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.184","doi-asserted-by":"crossref","unstructured":"Van Middendorp H, Berende A, Vos F, et al. Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease. Submitted 2020","DOI":"10.1007\/s10067-021-05760-1"},{"key":"2020062510350261000_369.may26_2.m1041.185","doi-asserted-by":"crossref","unstructured":"Jahfari S Hofhuis A Fonville M . Molecular detection of tick-borne pathogens in humans with tick bites and erythema migrans, in the Netherlands. PLoS Negl Trop Dis 2016;10:e0005042.","DOI":"10.1371\/journal.pntd.0005042"},{"key":"2020062510350261000_369.may26_2.m1041.186","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1355.069"},{"key":"2020062510350261000_369.may26_2.m1041.187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202018"},{"key":"2020062510350261000_369.may26_2.m1041.188","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2015.03.008"},{"key":"2020062510350261000_369.may26_2.m1041.189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.01022.x"},{"key":"2020062510350261000_369.may26_2.m1041.190","doi-asserted-by":"publisher","DOI":"10.3201\/eid0302.970209"},{"key":"2020062510350261000_369.may26_2.m1041.191","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1807870"},{"key":"2020062510350261000_369.may26_2.m1041.192","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6626a2"},{"key":"2020062510350261000_369.may26_2.m1041.193","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010493"},{"key":"2020062510350261000_369.may26_2.m1041.194","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.02.030"},{"key":"2020062510350261000_369.may26_2.m1041.195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/22221751.2019.1584017","article-title":"Cultivation of the causative agent of human neoehrlichiosis from clinical isolates identifies vascular endothelium as a target of infection","volume":"8","author":"Wass","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"2020062510350261000_369.may26_2.m1041.196","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1215469"},{"key":"2020062510350261000_369.may26_2.m1041.197","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805068"},{"key":"2020062510350261000_369.may26_2.m1041.198","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.12.001"},{"key":"2020062510350261000_369.may26_2.m1041.199","doi-asserted-by":"crossref","unstructured":"Strle F Bogovic P Cimperman J . Are patients with erythema migrans who have leukopenia and\/or thrombocytopenia coinfected with Anaplasma phagocytophilum or tick-borne encephalitis virus? PLoS One 2014;9:e103188.","DOI":"10.1371\/journal.pone.0103188"},{"key":"2020062510350261000_369.may26_2.m1041.200","doi-asserted-by":"publisher","DOI":"10.1086\/368187"},{"key":"2020062510350261000_369.may26_2.m1041.201","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.3359-3371.2001"},{"key":"2020062510350261000_369.may26_2.m1041.202","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530450047031"},{"key":"2020062510350261000_369.may26_2.m1041.203","doi-asserted-by":"crossref","unstructured":"Kobayashi T Higgins Y Samuels R . Misdiagnosis of Lyme disease with unnecessary antimicrobial treatment characterizes patients referred to an academic infectious diseases clinic. Open Forum Infect Dis 2019;6:ofz299.","DOI":"10.1093\/ofid\/ofz299"},{"key":"2020062510350261000_369.may26_2.m1041.204","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450201"},{"key":"2020062510350261000_369.may26_2.m1041.205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(16)30529-1","article-title":"Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial","volume":"17","author":"Schwameis","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.206","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medmal.2019.05.001","article-title":"Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis","volume":"49","author":"Jaulhac","year":"2019","journal-title":"Med Mal Infect"},{"key":"2020062510350261000_369.may26_2.m1041.207","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1261"},{"key":"2020062510350261000_369.may26_2.m1041.208","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390401"},{"key":"2020062510350261000_369.may26_2.m1041.209","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390402"},{"key":"2020062510350261000_369.may26_2.m1041.210","doi-asserted-by":"publisher","DOI":"10.3201\/eid0503.990302"},{"key":"2020062510350261000_369.may26_2.m1041.211","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.4.554"},{"key":"2020062510350261000_369.may26_2.m1041.212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nm0402-311b","article-title":"Poor sales trigger vaccine withdrawal","volume":"8","author":"Hitt","year":"2002","journal-title":"Nat Med"},{"key":"2020062510350261000_369.may26_2.m1041.213","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-0009.2012.00663.x"},{"key":"2020062510350261000_369.may26_2.m1041.214","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806007096"},{"key":"2020062510350261000_369.may26_2.m1041.215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/jvim.15344","article-title":"Efficacy of Borrelia burgdorferi vaccine in dogs in North America: A systematic review and meta-analysis","volume":"33","author":"Vogt","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2020062510350261000_369.may26_2.m1041.216","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq118"},{"key":"2020062510350261000_369.may26_2.m1041.217","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00406-14"},{"key":"2020062510350261000_369.may26_2.m1041.218","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70110-5"},{"key":"2020062510350261000_369.may26_2.m1041.219","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.vaccine.2015.07.095","article-title":"Characterization and optimization of a novel vaccine for protection against Lyme borreliosis","volume":"33","author":"Comstedt","year":"2015","journal-title":"Vaccine"},{"key":"2020062510350261000_369.may26_2.m1041.220","unstructured":"Valneva. Valneva reports positive initial booster data and final phase 1 data for its Lyme disease vaccine candidate. 2019. https:\/\/valneva.com\/press-release\/valneva-reports-positive-initial-booster-data-and-final-phase-1-data-for-its-lyme-disease-vaccine-candidate\/"},{"key":"2020062510350261000_369.may26_2.m1041.221","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw013"},{"key":"2020062510350261000_369.may26_2.m1041.222","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2007.08.002"},{"key":"2020062510350261000_369.may26_2.m1041.223","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/ciz872","article-title":"Protective immunity and new vaccines for Lyme disease","volume":"70","author":"Gomes-Solecki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020062510350261000_369.may26_2.m1041.224","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1607146"},{"key":"2020062510350261000_369.may26_2.m1041.225","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000265517.66976.28"},{"key":"2020062510350261000_369.may26_2.m1041.226","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.940900"},{"key":"2020062510350261000_369.may26_2.m1041.227","unstructured":"Hofmann H, Fingerle V, Hunfeld KP, et al. Cutaneous Lyme borreliosis: guideline of the German Dermatology Society. Ger Med Sci 2017;15:Doc 14."},{"key":"2020062510350261000_369.may26_2.m1041.228","first-page":"309","article-title":"Diagnosis and treatment of tick-borne diseases recommendations of the Polish Society of Epidemiology and Infectious Diseases","volume":"69","author":"Pancewicz","year":"2015","journal-title":"Przegl Epidemiol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m1041","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m1041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T23:24:52Z","timestamp":1666653892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m1041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":228,"alternative-id":["10.1136\/bmj.m1041"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m1041","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]}}}